Circular RNA in Non-small Cell Lung Carcinoma: Identification of Targets and New Treatment Modalities

Area of Science:

• Oncology
• Molecular Biology
• Bioinformatics

Background:

• Non-small cell lung cancer (NSCLC) has a poor five-year survival rate (22%) despite existing treatments.
• Novel therapeutic targets and treatment modalities are crucial for improving NSCLC patient outcomes.
• Circular RNAs (circRNAs) are increasingly recognized for their roles in cancer progression.

Purpose of the Study:

• To identify up-regulated circRNAs that promote NSCLC growth in preclinical models.
• To explore circRNAs as potential therapeutic targets for NSCLC.
• To investigate the mechanisms by which circRNAs influence NSCLC progression.

Main Methods:

• PubMed database screening for up-regulated circRNAs in NSCLC.
• Evaluation of identified circRNAs in in vitro and in vivo (xenograft) preclinical models.
• Analysis of circRNA-microRNA (miR) interactions and their downstream effects on gene expression.

Main Results:

• Identified multiple circRNAs promoting NSCLC growth by up-regulating transmembrane receptors, secreted proteins, signaling pathways, splicing factors, transcription factors, and epigenetic modifiers.
• Demonstrated circRNAs function by sponging miRs, thereby preventing mRNA cleavage.
• Cataloged specific circRNAs involved in various oncogenic processes, including regulation of actin and high-mobility group proteins.

Conclusions:

• circRNAs represent promising novel targets for NSCLC therapy.
• Inhibition of identified circRNAs using small interfering RNAs (siRNA) or short hairpin RNAs (shRNA) is a viable preclinical strategy.
• Further validation of these circRNAs could lead to the development of small molecule or antibody-based therapies.